Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
975.0000 -44.25 (-4.34%)
NSE Sep 26, 2025 15:31 PM
Volume: 2.6M
High volume today

975.00
-4.34%
Reliance Securities
ff CDH has filed total 6 transdermal products and plans to file one (Lidocaine) in Q4FY17E. Management indicated the product pipeline of recently acquired Sentynl will be launched in next 18 months though revenue contribution would...
Zydus Lifesciences Ltd.'s price crossed below 50Day SMA today
More from Zydus Lifesciences Ltd.
Recommended